Introduction
The recent human pregnancies and births achieved using spermatids retrieved from testicular tissue (Fishel et al., 1995) and ejaculate (Tesarik et al., 1995) have generated new hope for patients suffering from previously intractable male factor infertility. However, this novel approach has also generated many concerns Fishel et al., 1996) , and so careful consideration of the biological aspects of spermatids is required while balancing the opportunities for treating infertile couples.
One of the concerns is the low incidence of fertilization with spermatids (Tesarik and Mendoza, 1996; Fishel et al., 1997) . One of the probable causes of the low success rate of spermatid microinjection is the incomplete transition of nuclear proteins from histone to protamine which has hardly begun in the round spermatids (Meistrich et al., 1978) . Histone to protamine transition is a continuous process throughout spermatid maturation (Grimes, 1986; Poccia, 1986) . The reduction of sperm nuclear disulphide (S-S) bonds (Perreault et al., 1987) followed by protamine to histone replacement (Nonchev and Tsanev, 1990) are prerequisite for sperm nuclear decondensation and male pronucleus formation (Montag et al., 1992) . The lack of protamine does not protect the spermatid nucleus from maturation promoting factors (M-phase promoting factors) of the oocyte, and consequently premature chromosome condensation (PCC) can occur (Tesarik, 1996) . This was particularly evident with microinjected hamster spermatid nuclei which lack the S-S bonds of protamine. These nuclei decondensed completely within only 5-10 min compared with hamster sperm nuclei, which are rich in protamine S-S bonds and require 45-60 min of contact with oocyte cytoplasm before they undergo decondensation (Perreault et al., 1987) . Hence to improve the incidence of fertilization, either the oocyte should be activated prior to spermatid microinjection (Kimura and Yanagimachi, 1995) or alternatively the spermatid should be injected at the most advanced stage possible (I. Aslam and S.Fishel, unpublished results) . In-vitro culture of round spermatids may enhance spermatid maturation and, therefore, possibly improve the incidence of fertilization.
Because the success rate with spermatid microinjection is low (Tesarik and Mendoza, 1996; Fishel et al., 1997) , repeated testicular biopsies for subsequent treatment cycles can compromise the already deficient but active seminiferous tubules. Therefore, there is also a need to investigate the effects of cryopreservation on the viability of spermatogenic cells used for in-vitro conception because the presence of non-viable spermatids will reduce the overall incidence of fertilization.
Here we have examined the effects of in-vitro culture and cryopreservation on isolated and purified populations of spermatogenic cells.
Materials and methods
Patients and consent During 1.5 years, from January 1995 to June 1996, testicular biopsies were obtained from 57 patients who were offered treatment at NURTURE (Nottingham University Research and Treatment Unit in Reproduction), Nottingham, UK and who also consented for the samples to be used for research purposes. These azoospermic patients were admitted for epididymal aspiration, but on the day of treatment sperm recovery failed and so testicular biopsies were taken for testicular sperm extraction (TESE). Out of 57 patients, 17 suffered from obstructive azoospermia and 40 from non-obstructive azoospermia (hypospermatogenesis, maturation arrest and Sertoli cell-only syndrome, diagnosed by previous diagnostic biopsies).
After enzymatic digestion, purified populations of primary spermatocytes, round spermatids and elongating spermatids were isolated from testicular biopsies of obstructive and non-obstructive azoospermic patients (Aslam et al., 1997) . Spermatids could be isolated from the testicular biopsies of all patients. Viability of cells in the mixture of spermatogenic cells after enzymatic digestion and in each population after separation was examined using the Trypan blue exclusion test (see below). Mixtures of cells obtained after enzymatic digestion of testicular tissues and three isolated purified populations (primary spermatocytes, round spermatids and elongating spermatids) from obstructive and non-obstructive azoospermic patients were cultured in vitro for 96 h. Viability of these cells was checked and their morphology examined before and then after 4, 8, 12 and 24 h and then at 24 h intervals during culture. Similarly, mixtures of cells obtained after enzymatic digestion of testicular tissues and three isolated purified populations (primary spermatocytes, round spermatids and elongating spermatids) from obstructive and non-obstructive azoospermic patients were cryopreserved (for 2 days-3 months). Viability of these cells was checked using the Trypan blue exclusion test before cryopreservation and after thawing.
Assessment of viability
Viability of the germ cells in cellular suspension obtained after enzymatic digestion and in each isolated fraction was determined using the Trypan blue exclusion test (Talbot and Chacon, 1981) . Trypan blue stains dead cells blue but does not permeate the membrane of living cells, and so they remain unstained (Phillips, 1973) . 0.4% Trypan blue solution (0.5 ml; T-8154; Sigma, Poole, UK) was added to 0.5 ml of cell suspension obtained after enzymatic digestion and to 0.5 ml of each isolated germ cell fraction in 15 ml Falcon tubes and mixed thoroughly. The mixture was allowed to stand for 10 min at room temperature and then centrifuged at 500 g at 4°C for 10 min. Supernatants were discarded and the pellets resuspended in 1 ml of enriched Krebs-Ringer bicarbonate medium (EKRB). A small droplet from each tube was transferred to the culture dish and observed under a microscope. Cells stained blue were considered dead.
In-vitro culture of spermatogenic cells
Spermatogenic cells were cultured in vitro using the method employed for mouse spermatogenic cells (Gerton and Millette, 1984) . Medium for the culture of germ cells was prepared using modified Eagle's minimum essential medium (M-2289; Sigma) supplemented with 15 mM HEPES (H-6147; Sigma), 1 mM pyruvic acid (sodium salt; P-4562; Sigma), 6 mM L-lactic acid (sodium salt; L-7022; Sigma), glutamine (G-5763; Sigma), 100 IU/ml penicillin (potassium salt; P-4687; Sigma), 100 µg/ml streptomycin (S-1217; Sigma) and 10% (v/v) fetal bovine serum (S-9510; Sigma).
Required fractions of spermatogenic cells were centrifuged. Using the standard aseptic technique, germ cells were resuspended in culture medium and cultured in tissue culture dishes (10 ml of culture medium per 100 mm dish) under 5% CO 2 in air, at 32°C rather than the usual 37°C to avoid the adverse effects of the higher temperature on cellular metabolism.
Morphology and viability of the in-vitro cultured spermatogenic cells
Morphology of the in-vitro cultured germ cells was examined. Cells were photographed using a Nomarski differential interference microscope after 4, 8, 12 and 24 h and then at each 24 h interval until 96 h. In-vitro cultured cells were also examined for their viability at the same intervals.
Cryopreservation
Suspensions of the mixed germ cells and required germ cell fractions were transferred to 15 ml cone-bottomed Falcon tubes. The cryoprotectant (Sperm Freeze; glycerol, 0.4% human serum albumin, HEPES; Micron, Sinit-Martins, Latem, Belgium) was added dropwise at a 1:1 ratio. The mixtures were left for 10 min at room temperature and then aliquoted into 0.25 ml straws. Straws were plugged with polyvinyl alcohol powder. After labelling the straws with the date and type of cell they were placed in the chamber of a programmable freezer (cell freezer R 204; Planer Biomed, Sunbury on Thames, Middlesex, UK). The programme was run with the following rates of cooling: -1°C/min from room temperature to -15°C, and then -10°C/min to -85°C. Once the temperature reached -85°C the straws were removed from the chamber and plunged immediately into liquid nitrogen for storage at -196°C.
Viability of cryopreserved spermatogenic cells
After thawing at room temperature, cryopreserved germ cells were washed twice with EKRB to remove the cryoprotectant. Cryopreserved germ cells from different patients were examined for their viability on different days (2 days-3 months after cryopreservation).
Data analysis
To determine viability and morphology, 100 cells per sample per patient at each time interval were examined. The data were analysed using a repeated measure ANOVA with two within-subject factors, group and time. SPSS for windows version 7.5 was used for the statistical analysis.
Results

Viability of spermatogenic cells before and after in-vitro culture
During in-vitro culture the spermatogenic cells remained viable for only a short period of time. cells from testicular tissues of obstructive and non-obstructive azoospermic patients showed similar results.
Morphology of spermatogenic cells before and after invitro culture
Throughout the culture period primary spermatocytes, elongating spermatids and other non-spermatogenic cells showed no change in their morphology. However,~22% of round spermatids showed the growth of flagella in both in-vitro culture of mixtures of spermatogenic cells and in-vitro culture of isolated round spermatid fractions. Except for the growth of a flagellum, no other morphological change was seen in the round spermatids. Table II 
Viability of spermatogenic cells after cryopreservation
Cryopreservation of spermatogenic cell suspensions and isolated populations of testicular tissues from obstructive and non-obstructive azoospermic patients showed similar results. Table III displays the viabilities (mean % Ϯ SD) of the mixed cell suspensions and of each isolated homogeneous fraction before and after cryopreservation. When mixed cell suspensions were cryopreserved significantly more cells lost their viability compared with when isolated homogeneous spermatogenic cell fractions were cryopreserved (P Ͻ 0.0005).
Discussion
The results presented here demonstrate that mixtures of spermatogenic cells and isolated homogeneous populations of sperm- (Figure 1) . Most of the round spermatids developed their flagella in the early stages of culture (4-8 h of culture), and the number with flagella then remained constant throughout the culture period. Most of the cells that developed flagella remained intact and viable throughout almost the entire culture period and were the last to lose their viability after between 60 and 72 h of culture (Figure 2) . The results also demonstrated that spermatogenic cells can be cryopreserved successfully. However, when mixed spermatogenic cell suspensions were cryopreserved more cells lost their viability, whereas more viable cells were recovered after cryopreservation when isolated homogeneous populations of spermatogenic cells were cryopreserved. In-vitro systems for the study of mammalian spermatogenesis are severely limited. Different culture methods have been used in the past to study mammalian spermatogenesis. In-vitro culture of testicular cells from sexually mature and immature rats have shown that spermatogonia and spermatocytes could survive for 3-4 weeks and spermatids for several days in culture, but there was no evidence that spermatogenesis continued in culture (Steinberger and Steinberger, 1966) . Organ cultures of testis also failed to allow the differentiation of male germ cells beyond the pachytene stage of the first meiotic prophase in rats (Steinberger, 1975) . However, when defined segments of rat seminiferous tubules were cultured it was noted that primary spermatocytes in pachytene or diplotene stages could complete two meiotic divisions to produce round spermatids with acrosomes. Many of the germ cells, however, showed degenerative changes with time. The viability of the cells dropped to 20% by day 6 (Parvinen et al., 1983) . These studies have shown that although in-vitro culture of spermatogenic cells failed to allow the differentiation of male germ cells, these cells could be maintained in vitro for a short period of time.
Survival of spermatogenic cells in culture and availability of the techniques used to obtain highly purified populations of spermatogenic cells at particular stages of spermatogenesis (Bellve, 1993; O'Brien, 1993) have led to studies of a variety of metabolic events. Millette and Moulding (1981) have shown, by the incorporation of [ 3 H]leucine, that spermatogenic cells actively synthesize numerous cellular proteins during in-vitro culture. For example, spermatocytes and round spermatids synthesize plasma membrane proteins (Gerton and Millette, 1986) and actin and tubulin (constituent proteins of the axial filament of a flagellum; O'Brien, 1987) in culture. During invitro culture, lactate proved to be the preferred substrate for spermatid metabolism. Spermatids also showed higher incorporation of amino acids during in-vitro culture at 34°C than at 38°C in the presence of glucose (Nakamura et al., 1984) . The higher temperature inhibited some aspects of protein synthesis (Nakamura et al., 1978) . Therefore we used lactate and a pyruvate-rich medium and cultured the spermatogenic cells at 32°C.
Throughout the maturation of spermatids the histone to protamine transition in the nucleoproteins is continuous. During the mid-spermatid stage of spermatogenesis in rats and in several other mammalian species all of the testis histone and many non-histone proteins are replaced by spermatidal basic proteins (Lanneau and Loir, 1982) . In rats the transitional proteins, designated TP1 and TP2, which are the major DNAbinding proteins found in spermatids (steps 13-15), start replacing the histones during steps 9-12 of the mid-spermatid stage of rat spermiogenesis (Grimes et al., 1977) . They are present for only~2 or 3 days before their replacement by protamine (Grimes, 1986) . Reduction of nuclear disulphide (S-S) bonds of these protamines (Perreault et al., 1987) , followed by protamine to histone replacement (Nonchev and Tsanev, 1990) , are prerequisite for sperm nuclear decondensation and male pronucleus formation (Montag et al., 1992) . As amino acids are an integral part of these nucleoproteins, it may be possible that in-vitro culture of the spermatids will enhance spermatid nucleoprotein transition and spermatid maturation and, therefore, improve the incidence of fertilization. Gerton and Millette (1984) observed that when mouse spermatogenic cells were cultured, flagella were generated by round spermatids that were previously lacking tails. Flagella were first detected clearly after 6.5 h of culture. After 24 h 20% of round spermatids had formed flagella, and round spermatids were the only spermatogenic cells capable of tail formation. Flagellar elongation was blocked by 1 µM demecolcine, an inhibitor of tubulin polymerization. Tubulin was also localized in flagella by indirect immunofluorescence. Acridine orange staining of developing acrosomes showed that all spermatids that formed flagella in culture were Golgi-phase spermatids (Gerton and Millette, 1984) . The results of this study are comparable with our results. Our study shows that human spermatogenic cells can be maintained in culture and cells remain viable for a short period of time. During the initial stages of culture (from 4 to 8 h)~22% of spermatids develop flagella. Only early round spermatids develop these flagella; elongating spermatids and spermatocytes showed no flagellar development. Flagellar growth was blocked by the addition of 1 µM demecolcine (tubulin polymerization inhibitor) to the culture medium (results not shown). We believe that this is the first report of limited in-vitro differentiation of spermiogenic stage human germ cells.
Cryopreservation of human spermatozoa and their use in in-vitro fertilization is now common practice. Even human testicular spermatozoa have been cryopreserved and used successfully for in-vitro conception (Craft and Tsirigotis, 1995) . Recently a study reported the successful cryopreservation of mouse round spermatids (Ogura et al., 1996) ; 75-85% of testicular cells were alive after thawing. On microinjection of frozen-thawed round spermatids~90% of oocytes were fertilized; 11% of embryos transferred to foster mothers developed into normal offspring. The results of this study suggest that if cryopreservation of human spermatids is successful, then they can also be used for the treatment of infertile males. Semi-thin sections of human testicular tissues were cryopreserved. On thawing, viable spermatozoa and spermatids were retrieved by enzymatic digestion of the tissue (Salzbrunn et al., 1996) . Because we are now able to fractionate human spermatogenic cells into pure and homogeneous subpopulations (Aslam et al., 1997) , we tried to cryopreserve these isolated fractions. Our results confirm that human spermatogenic cells can also be successfully cryopreserved. However, the results also showed that more cells lost their viability when mixtures of testicular cells were cryopreserved compared with when homogeneous isolated fractions of spermatogenic cells were cryopreserved. This could be due to intolerance to cryopreservation, cell lysis or toxins secreted by the non-spermatogenic cells in testicular cell suspensions. The results prove that human spermatogenic cells can be successfully cryopreserved but that the cryopreservation of isolated spermatogenic cells yields better results than the cryopreservation of whole testicular extracts.
The results of our study suggest that human spermatogenic cells (especially round spermatids) can be cultured in vitro, which may enhance spermatid maturation and possibly improve the incidence of fertilization. Even if this is not possible, the development of flagella by the round spermatids during invitro culture provides an excellent way of identifying their viability. We are currently carrying out microinjection studies using in-vitro cultured spermatids to determine the effect of in-vitro culture on the incidence of fertilization.
